{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:58:49Z","timestamp":1785398329342,"version":"3.56.0"},"posted":{"date-parts":[[2026,5,26]]},"group-title":"Cancer Biology","reference-count":28,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Pennsylvania State Department of Health Pediatric Cancer Research Foundation Grant"},{"name":"Four Diamonds Transformative Patient-Oriented Pediatric Cancer Research Project Grant"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,7,29]]},"abstract":"<jats:p>Activation of innate inflammatory signaling and tumor-specific antigen presentation in cancer cells provides a foundation for anti-cancer immunotherapies. Here, we show that the insulin-like growth factor 2 mRNA-binding proteins (IGF2BP1, IGF2BP2, and IGF2BP3), which are upregulated across diverse human malignancies, including acute myeloid leukemia (AML), suppress RNA-sensing pattern recognition receptor signaling and downstream ISRE- and NF-\u03baB-dependent transcription. Among these pathways, RIG-I signaling is particularly sensitive to IGF2BP-mediated inhibition. This suppressive effect is strongest when all three IGF2BP paralogs are co-expressed, especially in embryonic-like hematoendothelial cells and leukemia stem cells. Mechanistically, IGF2BPs suppress innate immune signaling by directly binding to TNFAIP3 mRNA and promoting its expression. Consequently, inhibition of IGF2BPs activates innate immune signaling and induces MHC class I gene expression in AML cells, highlighting IGF2BPs as promising therapeutic targets to enhance RIG-I- and TLR-based cancer immunotherapies.<\/jats:p>","DOI":"10.64898\/2026.05.22.726816","type":"posted-content","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T22:30:13Z","timestamp":1779834613000},"source":"Crossref","is-referenced-by-count":0,"title":["Oncofetal RNA-binding proteins of IGF2BP family suppress IRF-3 and NF-kB dependent transcription downstream of cytosolic RNA sensors"],"prefix":"10.64898","author":[{"given":"Garrett","family":"Knox","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruba","family":"Agili-Shaban","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Morrissey","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamveer","family":"Karamveer","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahsan","family":"Polash","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, MD, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wohlbowne","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanija","family":"Kinzy","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Keller","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Schell","sequence":"additional","affiliation":[{"name":"Department of Cell and Biological Systems, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hengst","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George-Lucian","family":"Moldovan","sequence":"additional","affiliation":[{"name":"Department of Molecular and Precision Medicine, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjia","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Division of Biostatistics and Bioinformatics, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arati","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Molecular and Precision Medicine, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Molecular and Precision Medicine, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Harhaj","sequence":"additional","affiliation":[{"name":"Department of Cell and Biological Systems, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Hafner","sequence":"additional","affiliation":[{"name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda, MD, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Statistics, Radiation Effects Research Foundation, Hiroshima, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Uzun","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Mahony","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Pennsylvania State University, University Park, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Elcheva","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Hematology and Oncology, Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, United States.;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"key":"2026052902551409000_2026.05.22.726816v1.1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.625833"},{"key":"2026052902551409000_2026.05.22.726816v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.041"},{"key":"2026052902551409000_2026.05.22.726816v1.3","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.130"},{"issue":"2","key":"2026052902551409000_2026.05.22.726816v1.4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41375-020-01066-4","article-title":"Targeting RNA-binding proteins in acute and chronic leukemia","volume":"35","year":"2021","journal-title":"Leukemia"},{"key":"2026052902551409000_2026.05.22.726816v1.5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.287540.116"},{"key":"2026052902551409000_2026.05.22.726816v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0656-9"},{"key":"2026052902551409000_2026.05.22.726816v1.7","doi-asserted-by":"crossref","unstructured":"Elcheva IA , et al. (2023) IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. Frontiers in Immunology 14.","DOI":"10.3389\/fimmu.2023.1297519"},{"key":"2026052902551409000_2026.05.22.726816v1.8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5372"},{"key":"2026052902551409000_2026.05.22.726816v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-019-0656-9"},{"key":"2026052902551409000_2026.05.22.726816v1.10","doi-asserted-by":"publisher","DOI":"10.3390\/v15071437"},{"key":"2026052902551409000_2026.05.22.726816v1.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.03.052"},{"key":"2026052902551409000_2026.05.22.726816v1.12","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-012-1186-z"},{"key":"2026052902551409000_2026.05.22.726816v1.13","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.10.4448-4464.2004"},{"key":"2026052902551409000_2026.05.22.726816v1.14","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/26.22.5036"},{"key":"2026052902551409000_2026.05.22.726816v1.15","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20180575"},{"issue":"2","key":"2026052902551409000_2026.05.22.726816v1.16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s12276-022-00735-x","article-title":"The m6A reader IGF2BP3 promotes acute myeloid leukemia progression by enhancing RCC2 stability","volume":"54","year":"2022","journal-title":"Experimental & Molecular Medicine"},{"key":"2026052902551409000_2026.05.22.726816v1.17","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.25626"},{"key":"2026052902551409000_2026.05.22.726816v1.18","doi-asserted-by":"crossref","unstructured":"Yang Y , Li H , Fotopoulou C , Cunnea P , & Zhao X (2022) Toll-like receptor-targeted anti-tumor therapies: Advances and challenges. Frontiers in Immunology Volume 13\u20132022.","DOI":"10.3389\/fimmu.2022.1049340"},{"issue":"2","key":"2026052902551409000_2026.05.22.726816v1.19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15698\/cst2021.02.242","article-title":"Innate RIG-I signaling restores antigen presentation in tumors and overcomes T cell resistance","volume":"5","year":"2021","journal-title":"Cell Stress"},{"key":"2026052902551409000_2026.05.22.726816v1.20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI131572"},{"issue":"4","key":"2026052902551409000_2026.05.22.726816v1.21","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41375-019-0639-x","article-title":"RIG-I-based immunotherapy enhances survival in preclinical AML models and sensitizes AML cells to checkpoint blockade","volume":"34","year":"2020","journal-title":"Leukemia"},{"key":"2026052902551409000_2026.05.22.726816v1.22","first-page":"7","article-title":"MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy","volume":"12","year":"2020","journal-title":"Cancers (Basel)"},{"key":"2026052902551409000_2026.05.22.726816v1.23","doi-asserted-by":"crossref","first-page":"101948","DOI":"10.1016\/j.mcp.2023.101948","article-title":"Pancancer analysis uncovers an immunological role and prognostic value of the m6A reader IGF2BP2 in pancreatic cancer","volume":"73","year":"2024","journal-title":"Mol Cell Probes"},{"issue":"3","key":"2026052902551409000_2026.05.22.726816v1.24","doi-asserted-by":"crossref","first-page":"189317","DOI":"10.1016\/j.bbcan.2025.189317","article-title":"The microbiota-m(6)A-metabolism axis: Implications for therapeutic strategies in gastrointestinal cancers","volume":"1880","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2026052902551409000_2026.05.22.726816v1.25","doi-asserted-by":"crossref","first-page":"115940","DOI":"10.1016\/j.ejmech.2023.115940","article-title":"Development of a specific and potent IGF2BP1 inhibitor: A promising therapeutic agent for IGF2BP1-expressing cancers","volume":"263","year":"2024","journal-title":"Eur J Med Chem"},{"key":"2026052902551409000_2026.05.22.726816v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2022.10.004"},{"issue":"Supplement 1","key":"2026052902551409000_2026.05.22.726816v1.27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1182\/blood-2024-204473","article-title":"Novel Small Molecule Inhibitor Against IGF2BP3 with Potent Anti-Leukemic Activity","volume":"144","year":"2024","journal-title":"Blood"},{"key":"2026052902551409000_2026.05.22.726816v1.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.10.005"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.05.22.726816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:05:13Z","timestamp":1785395113000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.05.22.726816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":28,"URL":"https:\/\/doi.org\/10.64898\/2026.05.22.726816","relation":{},"subject":[],"published":{"date-parts":[[2026,5,26]]},"subtype":"preprint"}}